The online version of this article (doi:10.1186/1752-1947-8-409) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
TMA was the major contributor in studying the case. WM and MA helped with literature review and editing the manuscript. LC acted as senior author. He was involved in editing the manuscript. All authors read and approved the final manuscript.
5-oxoproline (pyroglutamic acid), an organic acid intermediate of the gamma-glutamyl cycle, is a rare cause of high anion gap metabolic acidosis. Acetaminophen and several other drugs have been implicated in the development of transient 5-oxoprolinemia in adults. We believe that reporting all cases of 5-oxoprolinemia will contribute to a better understanding of this disease. Here, we report the case of a patient who developed transient 5-oxoprolinemia following therapeutic acetaminophen use.
A 75-year-old Caucasian woman was initially admitted for treatment of an infected hip prosthesis and subsequently developed transient high anion gap metabolic acidosis. Our patient received 40g of acetaminophen over a 10-day period. After the more common causes of high anion gap metabolic acidosis were excluded, a urinary organic acid screen revealed a markedly increased level of 5-oxoproline. The acidosis resolved completely after discontinuation of the acetaminophen.
5-oxoproline acidosis is an uncommon cause of high anion gap metabolic acidosis; however, it is likely that it is under-diagnosed as awareness of the condition remains low and testing can only be performed at specialized laboratories. The diagnosis should be suspected in cases of anion gap metabolic acidosis, particularly in patients with recent acetaminophen use in combination with sepsis, malnutrition, liver disease, pregnancy or renal failure. This case has particular interest in medicine, especially for the specialties of nephrology and orthopedics. We hope that it will add more information to the literature about this rare condition.
Authors’ original file for figure 113256_2014_3012_MOESM1_ESM.tif
Pitt JJ, Hauser S: Transient 5-oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects. Clin Chem. 1998, 44 (7): 1497-1503. PubMed
Kortmann W, Van Agtmael MA, van Diessen J, Kanen BL, Jakobs C, Nanayakkara PW: 5-oxoproline as a cause of high anion gap metabolic acidosis: an uncommon cause with common risk factors. Neth J Med. 2008, 66 (8): 354-357. PubMed
Liss DB, Paden MS, Schwarz ES, Mullins ME: What is the clinical significance of 5- oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?. Clin Toxicol. 2013, 51: 817-827. 10.3109/15563650.2013.844822. CrossRef
Peter JV, Rogers N, Murty S, Gerace R, Mackay R, Peake SL: An unusual cause of severe metabolic acidosis. Med J Aust. 2006, 185 (4): 223-225. PubMed
- Acetaminophen-induced anion gap metabolic acidosis secondary to 5-oxoproline: a case report
Tarig Mohammed Abkur
- BioMed Central